A direct flow cytometric erythrocyte immunofluorescence assay (FC) was developed and compared with the direct antiglobulin test (DAT) for detection of erythrocyte-bound immunoglobulin (IgG and IgM) and complement (C3) in dogs with immune-mediated hemolytic anemia (IMHA). Tests were performed on erythrocytes from 13 healthy nonanemic dogs and from 13 anemic dogs with IMHA. The FC and DAT were negative for erythrocyte-bound immunoglobulin in all healthy dogs. The FC was negative for erythrocyte-bound C3 in 12 healthy dogs and positive in 1 healthy dog, and the DAT was negative for C3 in all healthy dogs. Of the 13 IMHA dogs tested for erythrocyte-bound IgG, 12 were positive using the FC and 7 were positive using the DAT. Sensitivity for the detection of erythrocyte-bound IgG in the 26 dogs was 92% for FC and 53% for DAT. Specificity for detection of erythrocyte bound IgG for FC and DAT was 100%. The addition of IgM and/ or C3 did not increase the sensitivity for FC or DAT. In this group of dogs, the FC provided a more rapid, cost-effective, sensitive, objective method to quantitate erythrocyte-bound immunoglobulin and/or complement compared with the currently used DAT.
Immune-mediated hemolytic anemia (IMHA) is the most commonly diagnosed immune disorder in the dog. 8, 20 Laboratory findings most consistent with IMHA are regenerative anemia, spherocytosis, agglutination, and a positive direct antiglobulin test (DAT). 14 The disease is caused by accelerated destruction of erythrocytes due to antibodies of IgG and/or IgM immunoglobulin classes, with or without complement (C3), bound to red blood cell membranes. 2, 3, 9, 20 The DAT is the classic and most commonly used method for the detection of immunoglobulin and complement on red cell membranes. 5, 6 This technique is agglutination based, the interaction between antisera and erythrocyte-bound immunoglobulin results in visual agglutination of erythrocytes. The diagnosis of IMHA in dogs is supported by a positive test result. 5, 7, 12 This test method has several disadvantages, including a high proportion of false-negative results, 7, 11 high cost because of the large quantities of antisera required, and subjective interpretation of results. 12 Flow cytometry, a technique that allows cells to be assessed based on size, internal complexity, and amount of surface fluorescence, 10, 16 has been used to detect erythrocyte-bound antibodies in human. 1, 15, 21 Membrane-bound immunoglobulin can be labeled with fluorescein-conjugated antisera, and fluorescence can be precisely and rapidly quantitated. In contrast to the DAT, flow cytometry requires a small sample size, uses small quantities of antisera, and is an objective, quantitative method. 1, 15, 21 In this study, a direct flow cytometric method for detection of membrane-bound immunoglobulin and complement on erythrocytes of dogs with IMHA was used, and the results were compared with those of the DAT.
Material and methods
Sample acquisition. Disodium ethylenediaminetetraacetic acid anticoagulated (1 mg/ml) whole blood samples were obtained from 13 healthy dogs with hematocrits within the reference interval (0.37-0.55 L/L) a and from 13 untreated dogs with features of IMHA. Dogs with IMHA were selected based on anemia (hematocrit Յ 0.37 L/L), no evidence for other disorders inducing anemia, and the presence of spherocytes and/or erythrocyte agglutination. Samples were stored at 4 C for Յ48 hr before analysis.
DAT. Red cells from each sample were washed 3 times in 0.9% saline at 37 C, pH 7.4, and diluted to 2% in isotonic phosphate-buffered saline, pH 7.4, molarity 0.01 (PBS) with 0.1% ovalbumin (grade 5) b at 37 C. The DAT was performed as previously described 5 using a 96-well microtitration plate with serial dilutions of antisera ranging from 1:2 to 1:2,048. Antisera used included Coombs' reagent, c rabbit anti-dog IgG d (heavy and light chains), rabbit anti-dog IgM d ( chain specific), and goat anti-dog C3. d Fifty microliters of 2% red cells were incubated with antisera at 37 C for 1 hr, and agglutination was recorded as the last dilution in which erythrocyte mats were observed to cover Ͼ50% of the microtiter well.
Direct flow cytometric erythrocyte immunofluorescence assay. Fifty microliters of washed 1% red cells were incu- Samples were analyzed by flow cytometer e using an independent flow cytometry operator. Standardized fluorescein-labeled calibration beads f were used for instrument calibration, and dim-range fluorescein labeled g beads were used for a positive control. Calibration beads had similar size, excitation, and emission spectra as the fluorescein-labeled canine erythrocytes. 19 Forward and side (orthogonal) scattering signals and fluorescein-generated fluorescence (488 nm) signals were collected in list mode. Gates were set to identify red cells and fluorescein-labeled beads. For each sample, the median fluorescence channel was recorded for 10,000 red cells or FITC-labeled beads. A software program h was used for calculation of molecules of equivalent soluble fluorochrome (MESF) 19 from the median channel number. The MESF values from 13 healthy nonanemic dogs were used to establish a reference interval. A test sample was considered positive if the MESF was Ͼ2 SD above the mean for clinically normal dogs and was considered negative if the MESF fell below this value. Erythrocytes from healthy dogs and dim-range fluorescein-labeled beads were run in conjunction with each test sample.
Statistical analysis. Sensitivity of the tests was defined as the number of dogs with IMHA that tested positive and specificity was defined as the number of healthy dogs that tested negative. Positive predictive value was defined as the number of dogs that tested positive that had IMHA, and negative predictive value was defined as the number of dogs that tested negative that did not have IMHA. Agreement between test methods was determined using kappa values. 18 Ninetyfive percent confidence intervals (95% CI) are reported along with sensitivity, specificity, positive/negative predictive values, and kappa value.
Results
The direct flow cytometric erythrocyte immunofluorescence assay (FC) and DAT were negative for erythrocyte-bound immunoglobulin in all healthy dogs. The FC for erythrocyte-bound C3 was negative in 12 healthy dogs and positive in 1 healthy dog, and the DAT was negative for C3 in all healthy dogs. The upper reference interval for the FC, using healthy dogs, was 667 MESF for IgG, 594 MESF for IgM, and 755 MESF for C3. MESF values for all healthy dogs were slightly greater than those for nonlabeled calibration beads and nonlabeled erythrocytes.
IgG. Of the 13 IMHA dogs tested for erythrocytebound IgG, 12 were positive using the FC and 7 were positive using the DAT ( Table 1) . Results of the DAT using Coombs' reagent was the same as that for erythrocyte-bound IgG. Sensitivity for the detection of erythrocyte-bound IgG in this group of dogs was 92% (95% CI ϭ 78-100%) for FC and 53% (27-80%) for the DAT. Specificity and positive predictive value for detection of erythrocyte-bound IgG in this group of dogs using the FC and DAT were 100% (95% CI ϭ 100%). The negative predictive value for detection of erythrocyte-bound IgG in this group of dogs was 93% (95% CI ϭ 78-100%) for FC and 68% (48-89%) for DAT. Additional testing for erythrocyte-bound IgM and/or C3 did not increase the sensitivity, specificity, or positive/negative predictive values for FC or DAT in our study population. The kappa value for agreement between the FC and DAT for detection of IgG was 0.60 (95% CI ϭ 0.24-0.95).
IgM.
Of the 13 IMHA dogs tested for erythrocytebound IgM, 11 were positive using FC and 1 was positive using the DAT ( Table 1 ). The kappa value for agreement between the FC and the DAT for detection of IgM was 0.16 (95% CI ϭ Ϫ0.06 to 0.38).
C3. Of the 13 IMHA dogs tested for erythrocytebound C3, 6 were positive using FC and 1 was positive using the DAT ( Table 1 ). The kappa value for agreement between the FC and DAT for detection of C3 was 0.24 (95% CI ϭ Ϫ0.12 to 0.48).
MESF. Dogs 1, 3, 5, 9, and 12 had hematocrits of Յ0.15 L/L. Cumulative MESF for membrane-bound IgG, IgM, and C3 was highest (Ͼ7,500 MESF) for dogs 3, 5, and 9. All other dogs had cumulative MESF values of Յ4,026.
Discussion
In this study, a direct flow cytometric method for detection of erythrocyte-bound immunoglobulin and complement was developed and tested in a group of dogs with IMHA. Results of this test method were compared with those of the DAT. The FC method detected more IMHA dogs than did the DAT. Agreement between test methods for detection of IgG was moderate, 18 and agreement for detection of IgM and C3 was fair to slight. 18 These results are similar to those previously published for humans, in whom flow cytometry has been found to be more sensitive than DAT for the detection of IgG and complement on red cell membranes. 1, 15, 21 All 3 erythrocyte-bound constituents, IgG, IgM, and C3, were detected in 46% of IMHA dogs, and IgG/ IgM was detected in 83% of IMHA dogs using FC as compared with 8% with the DAT. This finding is similar to that in a previous report, 13 where 93% of canine primary IMHA cases were associated with the presence of erythrocyte-bound IgG, IgM, and C3, when a direct enzyme-linked antiglobulin test was used.
The MESF for IgG, IgM, and C3 in healthy dogs was greater than that for nonlabeled erythrocytes and blank beads, which suggests the presence of small amounts of erythrocyte-bound immunoglobulin and complement in these animals. These small amounts were not detected using the DAT. The presence of erythrocyte-bound immunoglobulin and complement in healthy dogs has been previously reported 13 and is thought to be associated with the removal of senescent erythrocytes from circulation. 3, 17 The IMHA dogs with negative DAT results had lower cumulative MESF for erythrocyte-bound IgG, IgM, and C3, ranging from 1,291 to 4,026. Flow cytometry provides excellent linear correlation between amount of erythrocyte-bound IgG and level of immunofluorescence, 21 but the DAT has been shown to be poorly correlated with the amount of erythrocyte-bound immunoglobulin. 21 Results presented in this study suggest that the DAT was unable to detect small amounts of erythrocyte-bound immunoglobulin and/or complement in all 13 healthy dogs and in 6 dogs with IMHA. Dogs 3, 5, and 9 had very high cumulative MESF values (Ͼ7,000 for IgG, IgM, and C3). These dogs had hematocrits of Յ0.15 L/L, suggesting severe hemolysis. Because increased MESF represents an increased amount of erythrocyte-bound immunoglobulin/complement 19 and large amounts of erythrocyte-bound IgG and IgM have been associated with increased severity of IMHA, 13, 21 the MESF may be useful to predict the severity of disease. However, other researchers 4 using assays based on enzyme-linked immunosorbent assays have been unable to detect a relationship between amount of erythrocyte-bound immunoglobulin and complement detected and the severity of disease in dogs diagnosed with IMHA. Further studies are required to define this relationship.
In this study, there was one dog (dog 1) with severe anemia but negative DAT and FC results. The reason why the FC failed to detect increased amounts of immunoglobulin and complement in this dog is unknown. The criteria used for inclusion of dogs in this study may have allowed inclusion of dogs with diseases other than IMHA because there are no definitive criteria for the diagnosis of IMHA. Alternatively, dog 1 may have had cold agglutinating antibodies associated with the red cell membranes that were eluted during the initial wash with warm saline. There was insufficient sample to perform the FC and DAT under cold conditions to investigate this hypothesis.
Positive and negative predictive values for test methods provide valuable information regarding test performance in a group of animals. 18 Based on this study, the positive predictive value of both the FC and the DAT was 100%, whereas the negative predictive value was lower for the DAT (68%) than for the FC (93%). Therefore, in this group of animals the FC was more likely to accurately differentiate between dogs that had IMHA and dogs that did not have IMHA. A correct diagnosis is important so affected dogs are appropriately treated and unaffected dogs are not treated with potentially harmful drugs. Further testing using the FC in dogs with other types of anemia is needed for a more critical review of this methodology.
There are many advantages to flow cytometry for the detection of erythrocyte-bound immunoglobulin and/or complement. In the method developed in this study, the calibration beads used were of similar size, excitation, and emission spetra as fluorescein-labeled canine erythrocytes. This similarity allowed calculation of MESF from a standardized calibration plot, which is instrument independent. Results can therefore be reproduced regardless of the type of flow cytometer used and can be compared within and between institutions. 19 In addition, this technique uses as little as 10 l of packed erythrocytes. In contrast, the DAT requires 250 l of packed red cells. A further advantage of the FC is decreased reagent costs because the FC uses about 10% of the antisera required for DAT. In this group of dogs, the FC provided a more rapid, costeffective, sensitive, objective method to quantitate erythrocyte-bound immunoglobulin and/or complement compared with the currently used DAT.
